TUB Fundamental Analysis - FINANCIERE DE TUBIZE

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to TUB. TUB was compared to 54 industry peers in the Pharmaceuticals industry. TUB has a great financial health rating, but its profitability evaluates not so good. TUB is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

TUB had positive earnings in the past year.

TUB had a negative operating cash flow in the past year.

In the past 5 years TUB has always been profitable.

In the past 5 years TUB always reported negative operating cash flow.

1.2 Ratios

TUB's Return On Assets of 4.79% is in line compared to the rest of the industry. TUB outperforms 48.15% of its industry peers.

Looking at the Return On Equity, with a value of 4.79%, TUB is in line with its industry, outperforming 40.74% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	4.79%
ROE	4.79%
ROIC	N/A

ROA(3y)4.63%

ROA(5y)5.57%

ROE(3y)4.88%

ROE(5y)5.78%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for TUB so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, TUB has about the same amount of shares outstanding.

TUB has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, TUB has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 15719.20 indicates that TUB is not in any danger for bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 15719.20, TUB belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

There is no outstanding debt for TUB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	15719.2

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

TUB has a Current Ratio of 10.33. This indicates that TUB is financially healthy and has no problem in meeting its short term obligations.

TUB has a better Current ratio (10.33) than 100.00% of its industry peers.

A Quick Ratio of 10.33 indicates that TUB has no problem at all paying its short term obligations.

With an excellent Quick ratio value of 10.33, TUB belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	10.33
Quick Ratio	10.33

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.02% over the past year.

TUB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.68% yearly.

EPS 1Y (TTM)3.02%

EPS 3Y2.13%

EPS 5Y-20.68%

EPS Q2Q%2.84%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

TUB is valuated quite expensively with a Price/Earnings ratio of 103.61.

66.67% of the companies in the same industry are cheaper than TUB, based on the Price/Earnings ratio.

Compared to an average S&P500 Price/Earnings ratio of 26.59, TUB is valued quite expensively.

		Industry Rank	Sector Rank
PE	103.61
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

TUB has a yearly dividend return of 0.34%, which is pretty low.

Compared to an average industry Dividend Yield of 2.90, TUB is paying slightly less dividend.

With a Dividend Yield of 0.34, TUB pays less dividend than the S&P500 average, which is at 2.31.

		Industry Rank	Sector Rank
Dividend Yield	0.34%

5.2 History

On average, the dividend of TUB grows each year by 7.33%, which is quite nice.

Dividend Growth(5Y)7.33%

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

0.05% of the earnings are spent on dividend by TUB. This is a low number and sustainable payout ratio.

DP0.05%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

FINANCIERE DE TUBIZE

EBR:TUB (12/11/2025, 9:25:58 AM)

215.5

-0.5 (-0.23%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)08-02 2025-08-02

Earnings (Next)03-21 2026-03-21

Inst Owners4.74%

Inst Owner ChangeN/A

Ins Owners33.27%

Ins Owner ChangeN/A

Market Cap9.59B

Revenue(TTM)N/A

Net Income(TTM)92.74M

Analysts76.67

Price Target235.11 (9.1%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0.34%

Yearly Dividend0.97

Dividend Growth(5Y)7.33%

DP0.05%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)23.76%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	103.61
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	4.95
P/tB	4.95
EV/EBITDA	N/A

EPS(TTM)2.08

EY0.97%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.03

FCFYN/A

OCF(TTM)-0.03

OCFYN/A

SpS0

BVpS43.5

TBVpS43.5

PEG (NY)N/A

PEG (5Y)N/A

Graham Number45.12

Profitability

		Industry Rank	Sector Rank
ROA	4.79%
ROE	4.79%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)4.63%

ROA(5y)5.57%

ROE(3y)4.88%

ROE(5y)5.78%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score6

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	10.33
Quick Ratio	10.33
Altman-Z	15719.2

F-Score6

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)3.02%

EPS 3Y2.13%

EPS 5Y-20.68%

EPS Q2Q%2.84%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-29.07%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-0.98%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-0.98%

OCF growth 3YN/A

OCF growth 5YN/A

FINANCIERE DE TUBIZE / TUB.BR FAQ

What is the fundamental rating for TUB stock?

ChartMill assigns a fundamental rating of 3 / 10 to TUB.BR.

What is the valuation status for TUB stock?

ChartMill assigns a valuation rating of 0 / 10 to FINANCIERE DE TUBIZE (TUB.BR). This can be considered as Overvalued.

How profitable is FINANCIERE DE TUBIZE (TUB.BR) stock?

FINANCIERE DE TUBIZE (TUB.BR) has a profitability rating of 2 / 10.

What is the valuation of FINANCIERE DE TUBIZE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FINANCIERE DE TUBIZE (TUB.BR) is 103.61 and the Price/Book (PB) ratio is 4.95.

Can you provide the financial health for TUB stock?

The financial health rating of FINANCIERE DE TUBIZE (TUB.BR) is 9 / 10.

FINANCIERE DE TUBIZE (TUB.BR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

FINANCIERE DE TUBIZE / TUB.BR FAQ

What is the fundamental rating for TUB stock?

What is the valuation status for TUB stock?

How profitable is FINANCIERE DE TUBIZE (TUB.BR) stock?

What is the valuation of FINANCIERE DE TUBIZE based on its PE and PB ratios?

Can you provide the financial health for TUB stock?